Navigate Ventures is pleased to announce it has made an investment in Preveta, an AI-powered care navigation platform that integrates clinical data into specialty care workflows - particularly in oncology, urology, and gastrointestinal specialties. Preveta empowers care teams to identify patients in need of intervention, surface treatment opportunities, and close gaps in care.

‍

Preveta is an AI-powered care navigation platform that helps specialty care teams - particularly in oncology, urology, and GI - deliver proactive, pathway-driven patient care. By structuring EMR data into intelligent workflows, Preveta enables care teams to identify patients needing intervention, surface treatment opportunities, and close gaps in care. The platform guides navigators with prioritized daily actions and integrates seamlessly into existing clinical operations, improving coordination, standardizing care delivery, and supporting better patient outcomes.

Preveta is led by CEO Victor Lee, a data scientist and repeat founder who has built and scaled multiple data science teams and enterprise platforms across healthcare, defense, and retail. He architected one of the first large-language-models for U.S. intelligence sharing and later led teams that built enterprise data lakes for some of the world’s largest retailers, including Walmart and Target. His hallmark is assembling and guiding teams that thrive under complexity, turning fragmented data into clarity at scale. At Preveta, he’s channeling that expertise into healthcare - transforming clinical data into pathway-driven insights that close care gaps and save lives.

"What stands out about Ivan is the way he leans in with conviction when he sees founders who know their craft and care deeply about their mission. He engages immediately, offering grounded insight and pragmatic support that makes a difference." - Victor Lee, CEO, Preveta

‍

Why We Invested

Preveta offers a truly innovative and mission-driven solution in specialty care. Their AI-powered platform integrates EHR data into clinical pathways fills gaps in care and improves outcomes through cleaner, richer data. Equally important, we were deeply impressed by the Preveta team. They combine deep clinical expertise, technical excellence and a founder-led passion for transforming care, making them exactly the type of team we want to back.

Co-investors include: Bullpen Capital, Sovereign’s Capital, TMV (TrailMix Ventures).

We are pleased to welcome Preveta to our family of portfolio companies at Navigate Ventures.

‍